NASDAQ
NGM Biopharmaceuticals, Inc. (NGM) has a free cash flow growth of 15.67% as of Friday, May 29, 2026. This represents a 784.41% increase compared to its 12-month average of -2.29%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.